Article
MiR-1299 Impedes the Progression of Non-Small-Cell Lung Cancer Through EGFR/PI3K/AKT…
OncoTargets and Therapy · 2020 · Cao S, Li L, Li J, Zhao H
Key facts
| Title | MiR-1299 Impedes the Progression of Non-Small-Cell Lung Cancer Through EGFR/PI3K/AKT Signaling Pathway |
|---|---|
| First author | Cao S, Li L, Li J, Zhao H |
| Journal | OncoTargets and Therapy |
| Published | Jul 30, 2020 |
| DOI | 10.2147/OTT.S250396 |
| Devices mentioned | K922230 |
| Product codes mentioned | JQB, MTX |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1